标题
The Role of PPAR and Its Cross-Talk with CAR and LXR in Obesity and Atherosclerosis
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 4, Pages 1260
出版商
MDPI AG
发表日期
2018-04-24
DOI
10.3390/ijms19041260
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders
- (2018) Xavier Palomer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis
- (2018) Shreekrishna Lamichane et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The challenges and promise of targeting the Liver X Receptors for treatment of inflammatory disease
- (2018) Michael B. Fessler PHARMACOLOGY & THERAPEUTICS
- The CAR agonist TCPOBOP inhibits lipogenesis and promotes fibrosis in the mammary gland of adolescent female mice
- (2018) Pengfei Xu et al. TOXICOLOGY LETTERS
- PPARγ Modulates Long Chain Fatty Acid Processing in the Intestinal Epithelium
- (2017) Kalina Duszka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Melatonin prevents obesity through modulation of gut microbiota in mice
- (2017) Pengfei Xu et al. JOURNAL OF PINEAL RESEARCH
- DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E–Deficient Mice
- (2017) Jing Wang et al. Journal of the American Heart Association
- Microbiome Remodeling via the Montmorillonite Adsorption-Excretion Axis Prevents Obesity-related Metabolic Disorders
- (2017) Pengfei Xu et al. EBioMedicine
- The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis
- (2016) Nathalie Hennuyer et al. ATHEROSCLEROSIS
- Small-molecule modulators of PXR and CAR
- (2016) Sergio C. Chai et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Distinct Roles of Transcription Factors KLF4, Krox20, and Peroxisome Proliferator-Activated Receptor γ in Adipogenesis
- (2016) Young-Kwon Park et al. MOLECULAR AND CELLULAR BIOLOGY
- PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD
- (2016) Barbara Gross et al. Nature Reviews Endocrinology
- Preventive obesity agent montmorillonite adsorbs dietary lipids and enhances lipid excretion from the digestive tract
- (2016) Pengfei Xu et al. Scientific Reports
- PPAR-α Agonist Fenofibrate Decreased RANTES Levels in Type 2 Diabetes Patients with Hypertriglyceridemia
- (2016) Xiaomeng Feng et al. MEDICAL SCIENCE MONITOR
- A brief history of the discovery of PXR and CAR as xenobiotic receptors
- (2016) Jiong Yan et al. Acta Pharmaceutica Sinica B
- Liver X receptors at the intersection of lipid metabolism and atherogenesis
- (2015) Stephen D. Lee et al. ATHEROSCLEROSIS
- Obesity and Atherosclerosis: Mechanistic Insights
- (2015) Fina Lovren et al. CANADIAN JOURNAL OF CARDIOLOGY
- Targeting xenobiotic receptors PXR and CAR in human diseases
- (2015) Monimoy Banerjee et al. DRUG DISCOVERY TODAY
- Potent peroxisome proliferator-activated receptor- agonist treatment increases cholesterol efflux capacity in humans with the metabolic syndrome
- (2015) A. V. Khera et al. EUROPEAN HEART JOURNAL
- Small-molecule modulators of the constitutive androstane receptor
- (2015) Milu T Cherian et al. Expert Opinion on Drug Metabolism & Toxicology
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
- (2015) Michal Pawlak et al. JOURNAL OF HEPATOLOGY
- CAR Suppresses Hepatic Gluconeogenesis by Facilitating the Ubiquitination and Degradation of PGC1α
- (2015) Jie Gao et al. MOLECULAR ENDOCRINOLOGY
- Families of Nuclear Receptors in Vertebrate Models: Characteristic and Comparative Toxicological Perspective
- (2015) Yanbin Zhao et al. Scientific Reports
- Deciphering the roles of the constitutive androstane receptor in energy metabolism
- (2014) Jiong Yan et al. ACTA PHARMACOLOGICA SINICA
- Mitochondrial Biogenesis in Health and Disease. Molecular and Therapeutic Approaches
- (2014) Fabian Sanchis-Gomar et al. CURRENT PHARMACEUTICAL DESIGN
- Editorial (Thematic Issue: Mitochondrial Biogenesis: Pharmacological Approaches)
- (2014) Teresa Valero CURRENT PHARMACEUTICAL DESIGN
- Liver X Receptor: A Cardinal Target for Atherosclerosis and Beyond
- (2014) Mihir Parikh et al. Journal of Atherosclerosis and Thrombosis
- Liver X receptors in lipid metabolism: opportunities for drug discovery
- (2014) Cynthia Hong et al. NATURE REVIEWS DRUG DISCOVERY
- Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review
- (2014) Bogna Grygiel-Górniak Nutrition Journal
- Activation of the constitutive androstane receptor inhibits gluconeogenesis without affecting lipogenesis or fatty acid synthesis in human hepatocytes
- (2014) Caitlin Lynch et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Integrated physiology and systems biology of PPARα
- (2014) Sander Kersten Molecular Metabolism
- Honokiol: A non-adipogenic PPARγ agonist from nature
- (2013) Atanas G. Atanasov et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Amorfrutin B is an efficient natural peroxisome proliferator-activated receptor gamma (PPARγ) agonist with potent glucose-lowering properties
- (2013) C. Weidner et al. DIABETOLOGIA
- Role of the constitutive androstane receptor in obesity and type 2 diabetes: a case study of the endobiotic function of a xenobiotic receptor
- (2013) Mengxi Jiang et al. DRUG METABOLISM REVIEWS
- Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond
- (2013) Xiaojuan Chai et al. Expert Opinion on Drug Metabolism & Toxicology
- Liver X receptor modulators: a review of recently patented compounds (2009 – 2012)
- (2013) Jon Loren et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Targeting liver X receptors in inflammation
- (2013) Knut R Steffensen et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- PPARγ signaling and metabolism: the good, the bad and the future
- (2013) Maryam Ahmadian et al. NATURE MEDICINE
- Concurrent Activation of Liver X Receptor and Peroxisome Proliferator-Activated Receptor Alpha Exacerbates Hepatic Steatosis in High Fat Diet-Induced Obese Mice
- (2013) Mingming Gao et al. PLoS One
- PPAR-α as a Key Nutritional and Environmental Sensor for Metabolic Adaptation
- (2013) Alejandra V. Contreras et al. Advances in Nutrition
- Atherosclerosis as an Inflammatory Disease
- (2012) Antonino Tuttolomondo et al. CURRENT PHARMACEUTICAL DESIGN
- Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008–present)
- (2012) Christina Lamers et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Protection from liver fibrosis by a peroxisome proliferator-activated receptor agonist
- (2012) K. Iwaisako et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amorfrutins are potent antidiabetic dietary natural products
- (2012) C. Weidner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PPARs: Fatty acid sensors controlling metabolism
- (2012) Lars la Cour Poulsen et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- PPARs at the crossroads of lipid signaling and inflammation
- (2012) Walter Wahli et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Atherosclerosis: lessons from LXR and the intestine
- (2012) Barbara Bonamassa et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Liver X receptor biology and pharmacology: new pathways, challenges and opportunities
- (2012) Tomas Jakobsson et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Suppression of Chronic Damage in Renal Allografts by Liver X Receptor (LXR) Activation
- (2011) Eva Kiss et al. AMERICAN JOURNAL OF PATHOLOGY
- Constitutive Androstane Receptor Activation Decreases Plasma Apolipoprotein B–Containing Lipoproteins and Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice
- (2011) Anne-Laure Sberna et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- DBZ Blocks LPS-induced Monocyte Activation and Foam Cell Formation via Inhibiting Nuclear Factor-ĸB
- (2011) Xinni Xie et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Liver X Receptors in Atherosclerosis and Inflammation
- (2011) Seung-Soon Im et al. CIRCULATION RESEARCH
- Functional crosstalk of CAR–LXR and ROR–LXR in drug metabolism and lipid metabolism
- (2010) Lei Xiao et al. ADVANCED DRUG DELIVERY REVIEWS
- Intestinal Specific LXR Activation Stimulates Reverse Cholesterol Transport and Protects from Atherosclerosis
- (2010) Giuseppe Lo Sasso et al. Cell Metabolism
- Pregnane X Receptor and Constitutive Androstane Receptor at the Crossroads of Drug Metabolism and Energy Metabolism
- (2010) J. Gao et al. DRUG METABOLISM AND DISPOSITION
- Liver X receptor modulators: a review of recently patented compounds (2007 – 2009)
- (2010) Xiaolin Li et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Endogenous Ligands for Nuclear Receptors: Digging Deeper
- (2010) Michael Schupp et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Constitutive androstane receptor activation stimulates faecal bile acid excretion and reverse cholesterol transport in mice
- (2010) Anne Laure Sberna et al. JOURNAL OF HEPATOLOGY
- A Functional Cross-Talk between Liver X Receptor- and Constitutive Androstane Receptor Links Lipogenesis and Xenobiotic Responses
- (2010) Y. Zhai et al. MOLECULAR PHARMACOLOGY
- PPARαin Obesity: Sex Difference and Estrogen Involvement
- (2010) Michung Yoon PPAR Research
- Functional and genetic analysis in type 2 diabetes of Liver X receptor alleles – a cohort study
- (2009) Ingrid Dahlman et al. BMC Medical Genetics
- Constitutive androstane receptor mediates the induction of drug metabolism in mouse models of type 1 diabetes
- (2009) Bingning Dong et al. HEPATOLOGY
- The Constitutive Androstane Receptor Is an Anti-obesity Nuclear Receptor That Improves Insulin Sensitivity
- (2009) Jie Gao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Safety, Pharmacokinetics, and Pharmacodynamics of Single Doses of LXR-623, a Novel Liver X-Receptor Agonist, in Healthy Participants
- (2009) Arie Katz et al. JOURNAL OF CLINICAL PHARMACOLOGY
- LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse
- (2009) Elaine M. Quinet et al. JOURNAL OF LIPID RESEARCH
- The role of PPARα in lipid metabolism and obesity: Focusing on the effects of estrogen on PPARα actions
- (2009) Michung Yoon PHARMACOLOGICAL RESEARCH
- Emerging roles of peroxisome proliferator-activated receptor-β/δ in inflammation
- (2009) David Bishop-Bailey et al. PHARMACOLOGY & THERAPEUTICS
- Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease
- (2009) B. Dong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PXR and CAR in energy metabolism
- (2009) Taira Wada et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Fat and Beyond: The Diverse Biology of PPARγ
- (2008) Peter Tontonoz et al. Annual Review of Biochemistry
- Regulatory Cross-Talk between Drug Metabolism and Lipid Homeostasis: Constitutive Androstane Receptor and Pregnane X Receptor Increase Insig-1 Expression
- (2008) A. Roth et al. MOLECULAR PHARMACOLOGY
- Integration of metabolism and inflammation by lipid-activated nuclear receptors
- (2008) Steven J. Bensinger et al. NATURE
- The Role of PPARs in Cancer
- (2008) Keisuke Tachibana et al. PPAR Research
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started